Mental Disease Market Research Reports

We offer market research, industry forecasts, and business analysis in the Mental Disease as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter

Title Search

1 - 25 of 91 Products

Sort by

Display

Sleep Disorder Treatment Drugs Markets in China Product code:125560
Published by	Asia Market Information & Development
Published	May 25, 2013	Content info	195 Pages
Price	US $ 2000

Mental Illness Treatment Drugs Markets in China Product code:81740
Published by	Asia Market Information & Development
Published	May 1, 2013	Content info	222 Pages
Price	US $ 2000

Alzheimer disease - new drugs, markets and companies Product code:70927
Published by	Jain Pharmabiotech
Published	May 1, 2013	Content info
Price	US $ 3500

Research Report on China's Antidepressant Market, 2013-2017 Product code:258788
Published by	China Research and Intelligence
Published	December 26, 2012	Content info	Pages: 50
Price	US $ 2800

Antidepressants Market to 2018 - Despite Safety Concerns, Selective Serotonin Re-uptake Inhibitors (SSRIs) Continue to Dominate in the Absence of Effective Therapeutic Alternatives Product code:252729
Published by	GBI Research
Published	October 15, 2012	Content info	Pages: 110
Price	US $ 3500

Prescribing Influences: Bipolar Disorders - Improved control of bipolar depression persists as greatest unmet need Product code:250550
Published by	Datamonitor
Published	July 30, 2012	Content info	Pages: 74
Price	US $ 3800

Epidemiology: Social Anxiety Disorder - Highly co-morbid anxiety disorder will continue to remain a significant public health burden Product code:248099
Published by	Datamonitor
Published	July 25, 2012	Content info	Pages: 42
Price	US $ 5700

Market and Product Forecasts: Schizophrenia - The calm after the patent storm Product code:248078
Published by	Datamonitor
Published	July 13, 2012	Content info	Pages: 47
Price	US $ 11400

Prescribing Influences: Schizophrenia - Plethora of antipsychotics fail to address negative symptoms Product code:248079
Published by	Datamonitor
Published	June 26, 2012	Content info	Pages: 68
Price	US $ 3800

Analysis of the European Bipolar-disorder Therapeutics Market Product code:242214
Published by	Frost & Sullivan
Published	May 18, 2012	Content info
Price	US $ 6000

Treatment Algorithms: Schizophrenia - New antipsychotic launches underwhelm Product code:243913
Published by	Datamonitor
Published	May 15, 2012	Content info	Pages: 81
Price	US $ 7600

Product Profiles: Autism Spectrum Disorders - Growing interest in underserved market Product code:243934
Published by	Datamonitor
Published	April 26, 2012	Content info	Pages: 59
Price	US $ 3800

R&D Trends: Autism Spectrum Disorders - Pipeline growth reflects increasing interest in autism Product code:243933
Published by	Datamonitor
Published	April 16, 2012	Content info	Pages: 62
Price	US $ 3800

Case Study: Autism Spectrum Disorders - Public awareness and physician detailing will drive market growth Product code:243932
Published by	Datamonitor
Published	April 16, 2012	Content info	Pages: 36
Price	US $ 1900

Anxiety Disorders Product code:240207
Published by	Global Industry Analysts, Inc.
Published	April 1, 2012	Content info	Pages: 619
Price	US $ 4800

Psychiatry Partnering Terms and Agreements Product code:238157
Published by	Current Partnering, a division of Wildwood Ventures Limited
Published	March 30, 2012	Content info	722 Pages
Price	US $ 2695

R&D Trends: Depression - Clinical attrition driven by mature market conditions Product code:234118
Published by	Datamonitor
Published	January 25, 2012	Content info	Pages: 53
Price	US $ 3800

Depression Market Forecast Product code:234120
Published by	Datamonitor
Published	January 19, 2012	Content info
Price	US $ 11400

Market and Product Forecasts: Depression - Further clinical failures dampen growth prospects Product code:234119
Published by	Datamonitor
Published	January 19, 2012	Content info	Pages: 48
Price	US $ 11400

Product Profiles: Depression - Next generation vies for second-line patients Product code:234121
Published by	Datamonitor
Published	January 17, 2012	Content info	Pages: 225
Price	US $ 11400

Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules Product code:228474
Published by	GBI Research
Published	January 16, 2012	Content info	Pages: 87
Price	US $ 3500

Epidemiology: Depression - A significant economic burden on society and the individual Product code:234133
Published by	Datamonitor
Published	January 12, 2012	Content info	Pages: 43
Price	US $ 5700

Major Depressive Disorder (MDD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Product code:222282
Published by	GlobalData
Published	October 30, 2011	Content info	Pages: 100
Price	US $ 3500

Product Profiles: Schizophrenia - Adjunctive treatments to carve new niche in mature market Product code:229416
Published by	Datamonitor
Published	October 14, 2011	Content info	Pages: 193
Price	US $ 11400

Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Product code:217929
Published by	GlobalData
Published	October 11, 2011	Content info	Pages: 95
Price	US $ 3500

User Guide About Us Policies Site Map

Int'l: +1-860-674-8796 US: +1-866-353-3335 (Toll Free) | EU: +32-2-535-7543 | SG: +65-6223-2436